GMIM
ANIK icon

General Motors Investment Management’s Anika Therapeutics ANIK Stock Holding History

General Motors Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,255
Closed -$174K – 926
2013
Q2 		$174K Buy
+10,255
New +$148K 0.02% 819

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

General Motors Investment Management's ANIK Position: Q3 2013 in Review

General Motors Investment Management sold out of Anika Therapeutics (ANIK) in Q3 2013, closing a stake of 10,255 shares — an estimated $174K sold.

General Motors Investment Management first reported a position in ANIK in Q2 2013 and held it in 1 quarter. The position peaked at $174K in Q2 2013. 111 funds tracked by Wall St. Rank hold ANIK as of Q3 2013.

  • General Motors Investment Management reported no remaining Anika Therapeutics position as of Q3 2013 after selling out during the quarter.
  • General Motors Investment Management sold 10,255 Anika Therapeutics shares in Q3 2013, an estimated $174K.
  • General Motors Investment Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 1 quarter.
  • General Motors Investment Management's Anika Therapeutics position peaked at $174K in Q2 2013.
  • 111 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2013.

Based on General Motors Investment Management's 13F filing for Q3 2013, filed 29 Oct 2013.